Allen v. Takeda Pharmaceuticals North America
A jury in Lousiana awarded more than $9 billion to a New York couple in a bellwether trial in federal court over claims that taking diabetes drug Actos increases the risk of bladder cancer. The April 7 verdict, the first of 3,000-plus lawsuits coordinated before U.S. District Judge Rebecca Doherty in Lafayette, La., is bad news for defendants Takeda Pharmaceuticals USA Inc. and Eli Lilly & Co. They are represented by Sara Gourley at Sidley Austin and Bruce Parker at Venable, who tried the case together and are jointly overseeing the litigation.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
